Precigen, Inc. - stock earnings
PGEN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -33.1 million USD | 1.2 million USD |
| 2023Q3 | 87.4 million USD | 16.7 million USD |
| 2023Q2 | -20.3 million USD | 1.8 million USD |
| 2023Q1 | -22.7 million USD | 1.9 million USD |
| 2022Q4 | -22.2 million USD | 1.8 million USD |
| 2022Q3 | -7.6 million USD | 16.7 million USD |
| 2022Q2 | -26.1 million USD | 2.9 million USD |
| 2022Q1 | -19.3 million USD | 32.0 million USD |
| 2021Q4 | -25.0 million USD | 24.2 million USD |
| 2021Q3 | -29.8 million USD | 21.6 million USD |
| 2021Q2 | -20.1 million USD | 33.6 million USD |
| 2021Q1 | -17.3 million USD | 24.5 million USD |
| 2020Q4 | -41.7 million USD | 19.3 million USD |
| 2020Q3 | -29.5 million USD | 23.6 million USD |
| 2020Q2 | -43.4 million USD | 30.4 million USD |
| 2020Q1 | -56.0 million USD | 29.8 million USD |
| 2019Q4 | -169.2 million USD | 17.0 million USD |
| 2019Q3 | -53.6 million USD | 23.0 million USD |
| 2019Q2 | -38.8 million USD | 36.0 million USD |
| 2019Q1 | -60.7 million USD | 23.3 million USD |
| 2018Q4 | -340.5 million USD | 43.2 million USD |
| 2018Q3 | -57.3 million USD | 32.4 million USD |
| 2018Q2 | -65.4 million USD | 45.3 million USD |
| 2018Q1 | -42.0 million USD | 43.8 million USD |
| 2017Q4 | -27.3 million USD | 77.0 million USD |
| 2017Q3 | -39.7 million USD | 46.0 million USD |
| 2017Q2 | -18.7 million USD | 54.4 million USD |
| 2017Q1 | -31.4 million USD | 53.7 million USD |
| 2016Q4 | -44.1 million USD | 46.0 million USD |
| 2016Q3 | -29.0 million USD | 49.0 million USD |
| 2016Q2 | -49.1 million USD | 52.5 million USD |
| 2016Q1 | -64.4 million USD | 43.4 million USD |
| 2015Q4 | -32.7 million USD | 41.5 million USD |
| 2015Q3 | -38.2 million USD | 53.4 million USD |
| 2015Q2 | -40.7 million USD | 44.9 million USD |
| 2015Q1 | 27.1 million USD | 33.8 million USD |
| 2014Q4 | 18.8 million USD | 31.1 million USD |
| 2014Q3 | -52.7 million USD | 21.2 million USD |
| 2014Q2 | -52.0 million USD | 11.8 million USD |
| 2014Q1 | 4.1 million USD | 7.9 million USD |
| 2013Q4 | -12.2 million USD | 7.1 million USD |
| 2013Q3 | 15.4 million USD | 6.1 million USD |
| 2013Q2 | -6.0 million USD | 6.8 million USD |
| 2013Q1 | -36.3 million USD | 4.0 million USD |
| 2012Q4 | -30.9 million USD | 6.7 million USD |
| 2012Q3 | -20.5 million USD | 2.9 million USD |
| 2012Q2 | -16.5 million USD | 2.7 million USD |
| 2012Q1 | -13.9 million USD | 1.6 million USD |
PGEN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -95.9 million USD | 6.2 million USD |
| 2022 | -79.8 million USD | 26.9 million USD |
| 2021 | -96.8 million USD | 103.9 million USD |
| 2020 | -103.8 million USD | 103.2 million USD |
| 2019 | -207.8 million USD | 90.7 million USD |
| 2018 | -509.3 million USD | 160.6 million USD |
| 2017 | -117.0 million USD | 231.0 million USD |
| 2016 | -186.6 million USD | 190.9 million USD |
| 2015 | -84.5 million USD | 173.6 million USD |
| 2014 | -81.8 million USD | 71.9 million USD |
| 2013 | -39.0 million USD | 23.8 million USD |
| 2012 | -81.9 million USD | 13.9 million USD |
| 2011 | -85.3 million USD | 8.0 million USD |
PGEN
Price: $1.41
52 week price:
Earnings Per Share: -0.39 USD
P/E Ratio: -3.84
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 4.3 million
Market Capitalization: 348.5 million